CRDF

CRDF Operating Cash Flow Growth

2.37%TTM

Period ending:

CRDF TTM Cash from Operations YoY %%
CRDF TTM Cash from Operations YoY %147.30%-188.10%
2006-10-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

CRDF operating cash flow growth history

Year-over-year operating cash flow growth rate. The available trailing twelve months (ttm) series contains 62 observations from Oct 31, 2006 to Jun 30, 2026.

Cardiff Oncology Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
2.3683%
12.4687%
-0.6102%
-22.1554%
-30.4965%
-42.6422%
-22.0352%
-4.3062%
1.8398%
7.0183%
8.6724%
-4.142%
-9.6245%
-17.6063%
-46.7882%
-53.1727%
-58.2177%
-45.5829%
-41.2256%
-43.5928%
-33.2969%
-41.7351%
-22.966%
-6.3514%
-1.6857%
3.0762%
-0.5177%
-5.3075%
13.3306%
21.1528%
43.3058%
55.3864%
45.471%
47.1479%
24.9962%
-0.3834%
-9.1581%
-35.308%
-40.331%
-50.4093%
-54.332%
-65.7517%
-73.7908%
-78.9683%
-85.5725%
-72.7483%
-73.9368%
-58.0891%
-54.235%
-49.9984%
-48.2827%
-63.7303%
-95.7518%
-149.6203%
-155.642%
-128.7517%
-50.7098%
14.7412%
7.5524%
-7.3381%
12.9166%
114.8447%

Compare operating cash flow growth

All CRDF financial metrics · CRDF stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.